HCF/SF and its receptor c-MET play a minor role in the dissemination of human B-lymphoma cells in SCID mice

British Journal of Cancer

Volumn 81, Issue 1, 1999, Pages 43-53

  Weimar, I S ^a   Weijer, K ^a   Van Den Berk, P C M ^a   Muller, E J ^a   Miranda, N ^a,b   Bakker, A Q ^a   Heemskerk, M H M ^a   Hekman, A ^a   De Gast, G C ^a   Gerritsen, W R ^a,c  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b European Cancer Center   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

c MET; Dissemination; HGF SF; Human B lymphoma cells; Retroviral transduction; SCID mice

Indexed keywords

MATRIGEL; SCATTER FACTOR; TYROSINE KINASE RECEPTOR; COLLAGEN; LAMININ; PROTEOGLYCAN; SCATTER FACTOR RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; B CELL LYMPHOMA; CANCER INVASION; CARCINOGENICITY; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DAUDI CELL; ENDOTHELIUM CELL; GONAD; HUMAN; HUMAN CELL; KIDNEY; LIVER; LIVER METASTASIS; LUNG; LUNG METASTASIS; LYMPH NODE; LYMPH NODE METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTO ONCOGENE; SCID MOUSE; ANIMAL; ARMYWORM; BACULOVIRUS; BAGG ALBINO MOUSE; BIOSYNTHESIS; CANCER TRANSPLANTATION; CELL CULTURE; CELL MOTION; CELL STRAIN 3T3; DRUG COMBINATION; GENETIC TRANSDUCTION; GENETICS; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIROLOGY;

3T3 CELLS; ANIMALS; BACULOVIRIDAE; CELL MOVEMENT; COLLAGEN; DRUG COMBINATIONS; HEPATOCYTE GROWTH FACTOR; HUMANS; LAMININ; LYMPHOMA, B-CELL; MICE; MICE, INBRED BALB C; MICE, SCID; NEOPLASM TRANSPLANTATION; PROTEOGLYCANS; PROTO-ONCOGENE PROTEINS C-MET; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPODOPTERA; TRANSDUCTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0032588295     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690649     Document Type: Article

References (73)

1. Adams DH and Lloyd AR (1997) Chemokines: leucocyte recruitment and activation cytokines. Lancet 349: 400-495
2. Adams DH, Harvath L, Botlaro DP, Interrante R, Catalano G, Tanaka Y, Strain A, Hubscher SG and Shaw S (1994) Hepatocyte growth factor and macrophage inflammatory protein 1β: structurally distinct cytokines that induce rapid cytoskeletal changes and subset-preferential migration in T cells. Proc Natl Acad Sci USA 91: 7144-7148
3. Albini A, Iwamoto Y, Kleinman HK, Martin GR, Aaronson SA, Kozlowski JM and McEwan RN (1987) A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 47: 3239-3245
4. Appasamy R, Tanabe M, Murase N, Zarnegar R, Venkataramanan R, Van Thiel DH and Michalopoulos GK (1993) Hepatocyte growth factor, blood clearance, organ uptake, and biliary excretion in normal and partially hepatectomized rats. Lab Invest 68: 270-276
5. Baggiolini M, Dewald D and Moser R (1994) Interleukin-8 and related chemotactic cytokines: CXC and CC chemokines. Adv Immumol 55: 97-179
6. Bellusci S, Moens G, Gaudino G, Comoglio P, Nakamura T, Thiery J-P and Jouanneau J (1994) Creation of an hepatocyte growth factor/scatter factor autocrine loop in carcinoma cell induces invasive properties associated with increased tumorigenicity. Oncogene 9: 1091-1099
7. Berman ME, Xic Y and Muller WA (1996) Roles of platelet/endothelial cell adhesion molecule-1 (PECAM-1, CD31) in natural killer cell transendothelial migration and beta 2 integrin activation. J Immunol 156: 1515-1524
8. Bhargava M, Joseph A, Knesel J, Halaban R, Li Y, Pang S, Goldberg I, Setter E, Donovan MA, Zarnegar R, Micholopoulos GA, Nakamura T, Faletto D and Rosen EM (1992) Scatter factor and hepatocyte growth factor: activities, properties, and mechanism. Cell Growth Differ 3: 11-20
9. Bussolino F, Di Renzo MF, Ziche M, Bocchietto E, Olivero M, Naldini I., Gaudino G, Tamagnone L, Coffer A, Marchisio PC and Comoglio PM (1992) Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol 119: 629-641
10. Butcher EC and Picker LJ (1996) Lymphocyte homing and homeostasis. Science 272: 60-66
11. Carlos TM and Harlan JM (1994) Leukocyte-endothelial adhesion molecules. Blood 84: 2068-2101
12. Cesano A, O'Connor R, Lange B, Finan J, Rovera G and Santoli D (1991) Homing and progression patterns of childhood acute lymphoblastic leukemias in severe combined immunodeficient mice. Blood 77: 2463-2474
13. Cooper CS, Tempest PR, Beckman MP, Heldin CH and Brookees P (1986) Amplification ond overexpression of the met gene in spontaneously transformed NIH3T3 mouse fibroblasts. EMBO J 5: 2623-2628
14. DeGrendele HC, Estess P, Picker LJ and Siegelman MH (1996) CD44 and its ligand hyaluronate mediate rolling under physiological flow: a novel lymphocyte-endothelial cell primary adhesion pathway. J Exp Med 183: 1119-1130
15. de Kroon JF, Kluin PM, Kluin-Nelemans HC, Willemze R and Falkenburg JH (1994) Homing and antigenetic characterizalion of a human non-Hogdkin's lymphoma B cell line in severe combined immunodeficient (SCID) mice. Leukemia 8: 1385-1391
16. Dignass AU, Lynch-Devaney K and Podolsky DK (1994) Hepatocyte growth factor/scatter factor modulates intestinal epithelial cell proliferation and migration. Biochem Biophys Res Commun 202: 701-709
17. Di Renzo MF, Olivero M. Rerro S, Prat M, Bongarzone I, Pilotti S, Blefiore A, Constantino A, Vigneri R, Pierotti MA and Comoglio PM (1992) Overexpression of the c-MET/HGF receptor gene in human thyroid carcinomas. Oncogene 7: 2549-2553
18. Di Renzo MF, Olivero M, Giacomini A, Porte H, Chastre E, Mirossay L, Nordlinger B, Bretti S, Bottardi S, Giordano S, Plehani M, Gespach C and Comoglio PM (1995) Overexpression and amplification of the Met/HGF receptor gene during the progression of colorectal cancer. Clin Cancer Res 1: 147-154
19. Ferracini R, Di Renwo MF, Scotlandi K, Baldini N, Olivero M Lollini P, Cremona O, Campanacci M and Comoglio PM (1995) The Met/HGF receptor is overexpressed in human osteosarcorna and is activated by either a paracrine or an autocrine circuit. Oncogene 10: 739-749
20. Galimi F, Bagnara GP, Bonsi L, Cottone E, Follenzi A, Simeone A and Comoglio PM (1994) Hepatocyte growth factor induces proliferation and differentiation of multipoint and erythroid hemopoietic progenitors. J Cell Biol 127: 1743-1754
21. Gerardi E and Stoker M (1990) Hepatocytes and scatter factor. Nature 346: 228
22. Giordano S, Di Renzo MF, Narsimhan R, Cooper CS, Rosa C and Comoglio PM (1989) Biosynthesis of the protein encoded by the c-met proto-oncogene. Oncogene 4: 1383-1388
23. Giordano S, Zhen Z, Medico E, Gaudino G, Galami F and Comoglio PM (1993) Transfer of the motogenic and invasive response to scatter factor/hepatocyte growth factor by transfection of the human c-MET proto-oncogene. Proc Natll Acad Sci USA 90: 649-653
24. + progenitor cells are the result of c-met receptor expression. Stem Cells 14: 592-602
25. + hematopoietic progenitor cells. Radiat Res 147: 61-69
26. Grant DS, Kleinman HK, Goldber ID, Bhargava MM, Nickoloff BJ, Kinsella JL, Polverini PJ and Rosen EM (1993) Scatter factor induces blood vessel formation in vivo. Proc Natl Acad Sci USA 90; 1937-1941
27. Heernskerk MH, Blom B, Nolan G, Stegeman AP, Bakker AQ, Weijer K, Res PC and Spits H (1997) Inhibition of T cell and promotion of natural killer cell development by the dominant negative helix loop helix factor Id3. J Exp Med 186: 1597-1602
28. Hiscox S and Jiang WG (1997) Regulation of endothelial CD44 expression and endothelium tumour cell interactions by hepatocyte growth factor/scatter factor. Biochem Biophys Res Commun 233: 1-5
29. Hordijk P, ten Klooster JP, van der Kammen RA, Michiels F, Oomen LCJM and Collard JG (1997) Inhibition of invasion of epithelial cells by Tiam 1-Rac signaling. Science 278: 1464-1466
30. Iyer A, Kmiecik TE, Park M, Daar I, Blair D, Dunn KJ, Sutrave P, Ihle JN, Bodescot M and Vande Woude GF (1989) Structure, tissue-specific expression, and transforming activity of the mouse met proto-oncogene. Cell Growth & Differentiation 1: 87-95
31. Jeffers M, Rong S and VandeWoude GF (1996a) Hepatocyte growth factor/scatter factor-Met signaling in tumorigenicity and invasion/metastasis. J Mol Med 74: 505-513
32. Jeffers M, Rong S, Anver M and VandeWoude GF (1996b) Autocrine hepatocyte growth factor/scatter factor-Met signaling induces transformation and the invasive/metastatic phenotype in C127 cells. Oncogene 13: 853-856
33. Jücker M, Günther A, Gradl G, Fonatsch C, Krueger G, Diehl V and Tesch H (1994) The Met/Hepatocyte growth factor receptor (HGFR) gene is overexpressed in some cases of human leukemia and lymphoma. Leuk Res 18: 7-16
34. Kinsella TM and Nolan GP (1996) Episomal vectors rapidly and stably produce high-titer recombinant retrovirus. Human Gene Therapy 7: 1405-1413
35. Kmiecik TE, Keller JR, Rosen E and VandeWoude (1992) Hepatocyte growth factor is a synergistic factor for the growth of hematopoietic progenitor cells. Blood 80: 2454-2457
36. Lawrence MB and Springer TA (1991) Leukocytes roll on a selectin at physiologic flow rates: distinction from and prerequisite for adhesion through integrins. Cell 65: 859-873
37. Liu C, Park M and Tsa MS (1992) Overexpression of c-met proto-oncogene but not epidermal growth factor receptor or c-erB-2 in primary human colectoral carcinomas. Oncogene 7: 181-185
38. Mann R, Mulligan RC and Baltimore D (1983) Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus. Cell 33: 153-159
39. Matsuda Y, Matsumoto K, Iehida T and Nakamura T (1995) Hepatocyte growth factor suppresses the onset of liver cirrhosis and abrogates lethal hepatic dysfunction in rats. J Biochem 118; 643-649
40. Matsuda Y, Matsumoto K, Yamada A, Iehida T, Asakura HM, Komoriya Y, Nishiyama E and Nakamura T (1997) Preventive and therapeutic effects in rats of hepatocyte growth factor infusion on liver fibrosis/cirrhosis. Hepatology 26: 81-89
41. Michalopoulos GK (1990) Liver regeneration: molecular mechanisms of growth control. FASEB 4: 176-187
42. Mizuno K, Higuchi O, Ihle JN and Nakamura T (1993) Hepatocyte growth factor stimulates growth of hematopoietic progenitor cells. Biochem Biophys Res Commun 194: 178-1886
43. Mule JJ, Jieha DL and Rosenberg SA (1992) The use of congenitally immunodeficient mice to study human tumor metastases and immunotherapy. J Immunother 12: 196-198
44. Nakamura S, Gohda E, Matsunaga T, Yamamoto I and Minowada J (1994) Production of hepatocyte growth factor by human haematopoietic cell lines. Cytokine 6: 285-294
45. Nakamura T, Nishizawa T, Hagiya M, Seki T, Shimonishi M, Sugimura A, Tashiro K and Shimizu S (1989) Molecular cloning and expression of human hepatocyte growth factor. Nature 342: 440-443
46. Nakamura Y, Moritshita R, Higaki J, Kida I, Aoki M, Moriguchi A; Yamada K, Hayashi S, Yo Y, Nakano H, Matsumoto K, Nakamura T and Ogihara T (1996) Hepatocyte growth factor is a novel member of the endothelium specific growth factors: additive stimulatory effect of hepatocyte growth factor with basic fibroblast growth factor but not with vascular endothelial growth factor. J Hypertension 14; 1067-1072
47. Naldini L, Vigna E, Ferracini R, Longati P, Gandino L, Prat M and Comoglio PM (1991a) The tyrosine kinase encoded by the MET proto-oncogene is activated by autophosphorylation. Mol Cell Biol 11: 1793-1803
48. Naldini L, Vigna E, Narshiman RP, Gaudino G, Zarnegar R, Michalopoulos G and Comoglio PM (1991b) Hepatocyte growth factor (HGF) stimulates the tyrosine kinase activity of the receptor encoded by the proto-oncogene c-MET. Oncogene 6: 501-504
49. Natali PG, Nicotra MR, Di Renzo MR, Prat M, Bigotti A, Cavaliere R and Comoglio PM (1993) Expression of the c-Met/HGF receptor in human melanocytic neoplasms: demonstration of the relationship to malignant melanoma tumor expression. Br J Cancer 68: 746-750
50. Nishino T, Hisha H, Nishino N, Adachi M and Ikehara S (1995) Hepatocyte growth factor as a hematopoietic regulator. Blood 85: 3093-3100
51. Renz ME, Chiu HH, Jones S, Fox J, Kim KJ, Presta LG and Fong S (1994) Structural requirements for adhesion of soluble recombinant murine vascular cell adhesion molecule-1 to α4β1. J Cell Biol 125: 1395-1406
52. Rong S, Bodescot M, Blair D, Dunn J, Nakamura T, Mizuno K, Park M, Chan A, Aaronson S and Vande Woude GF (1992) Tumorigenicity of the met protooncogene and the gene for hepalocyte growth factor. Mol Cell Biol 12: 5152-5158
53. Rong S, Oskarsson M, Faletto D, Tsarfaty T, Reseau JH, Nakamura T, Rosen E, Hopkins III RF and Vande Woude GF (1993) Tumorigenesis induced by coexpression of human hepatocyte growth factor and the human met protooncogene leads to high levels of expression of the ligand and receptor. Cell Growth Differ 4: 563-569
54. Rong S, Segal S, Anver M, Reseau JH and Vande Woude GF (1994) Invasiveness and metastasis of NIH 3T3 cells induced by Met-hepatocyte growth factor/scatter factor autocrine stimulation. Proc Natl Acad Sci USA 91: 4731-4735
55. Rubin JS, Bottaro DP and Aaronson SA (1993) Hepatocyte growth factor/scatter factor and its receptor, the c-met proto-oncogene product. Biochem Biophys Acta 1155: 357-371
56. Springer TA (1994) Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76: 301-314
57. Stoker M, Gherardi E, Perryman M and Gray J (1987) Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature 327: 239-242
58. Strieter RM, Standiford TJ, Huffnagle GB, Colletti LM, Lukacs NW and Kunkel SL (1996) 'The good, the bad and the ugly.' The role of chemokines in models of human disease. J Immunol 516: 3583-3586
59. Schwartz MA, Tardelli L, Macosko HD, Sullivan LM, Narula SK and Fine JS (1995) Interleukin 4 retards dissemination of a human B-cell lymphoma in severe combined immunodeficient mice. Cancer Res 55: 3692-3696
60. Stroeken PJM, Van Rijthoven EA, Van der Valk MA and Roos E (1998) Targeted disruption of the beta-1 integrin gene in a lymphoma cell line greatly reduces metastatic capacity. Cancer Res 58: 1569-1577
61. Tavassoli M and Hardly C (1990) Molecular basis of homing of intravenously transplanted stem cells to the marrow. Blood 76; 1059-1070
62. Tsuzusi S, Toyama-Sorimachi N, Kitamura F, Tobita Y and Miyasaka M (1998) FK506 (tacrolimus) inibits extravasation of lymphoid cells by abrogating VLA-4/VCAM-1 mediated transendothelial migration. FEBS Lett 430; 414-418
63. Ueno S, Aikou T, Tanahe G, Kobayashi Y, Hamanoue M, Mitsue S, Kawaida K and Nakamura T (1996) Exogenous hepatocyte growth factor markedly stimulates liver regeneration following portal branch ligation in dogs. Cancer Chemother Pharmacol 38: 233-237
64. van der Voort R, Taher TE, Keehnen RM, Smit L, Groenink M and Pals ST (1997) Paracrine regulation of germinal center B cell adhesion through the c-met-hepatocyte growth factor/scatter factor pathway. J Exp Med 185: 2121-2131
65. Wakelin MW, Sanz MJ, Albelda SM, Larkin SW, Boughton-Smith N, Williams TJ and Nourshagh S (1996) An anti-platelet-endothelial cell adhesion molecule-1 antibody inhibits leukocyte extravasation from mesenteric microvessels in vivo by blocking the passage through the basement membrane. J Exp Med 184: 229-239
66. Walter J, Moller P, Moldenhauser G, Schirrmacher V, Pawlita M and Wolf J (1992) Local growth of a Burkitt's lymphoma versus disseminated invasive growth of the autologous EBV-immortalized lymphoblastoid cells and their somatic cell hybrids in SCID mice. Int J Cancer 50: 265-273
67. 1 integrins. Blood 89: 990-1000
68. +). Experimental Hematol 26: 885-894
69. Yee CJ, DeFrances MC, Bell A, Bowen W, Petersen B, Michalopoulos GK and Zarnegar R (1993) Expression and characterization of biologically active human hepatocyte growth factor (HGF) by insect cell infected with HGF-recombinant baculovirus. Biochemistry 32: 7922-7931
70. Zannettino ACW, Berndt MC, Butcher C, Butcher EC, Vadas MA and Simmons PJ (1995) Primitive human hematopoietic progenitors adhere to P-selectin (CD62P). Blood 85: 3466-3477
71. Zarnegar R and Michalopoulus G (1989) Purification and biological characterization of human hepatopoietin A, a polypeptide growth factor for hepatocytes. Cancer Res 49:3314-3320
72. Zarnegar R and Michalopoulos GK (1995) The many faces of hepatocyte growth factor: from hepatopoiesis to hematopoiesis. J Cell Biol 129: 1177-1180
73. Zioncheck TF, Richardson L, DeGuzman GG, Modi NB, Hansen SE and Gudowski PJ (1994) The pharmacokinetic, tissue localization, and metabolic processing of recombinant human hepatocyte growth factor after intravenous administration in rats. Endocrinology 134: 1879-1887